Preclin Biosystems
about us our models news and links join us contact us disclaimer
 
Models

Infectious disease

Autoimmune diseases

Lung diseases

Intestinal diseases

Preclin Biosystems’ approach

Preclin Biosystems AG

Preclin Biosystems AG offers a comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics.

Our extensive range of chronic inflammatory and infectious disease models are run routinely in our core facility providing a ‘one stop shop’ for preclinical drug efficacy testing. Our parallel testing approach for in vivo assessment of lead candidates can provide an overall efficacy, side effect and target market analysis condensing the preclinical phase of drug development dramatically. For more information on our service and partnership opportunities contact: info@preclinbiosystems.com
News

May 2009: Meet Preclin Biosystems AG at the 2009 Bio International Convention in Atlanta (17-21 May).
To schedule a meeting contact: info@preclinbiosystems.com

February 2009: Meet Preclin Biosystems AG at the BioEurope
2009 Spring conference in Milan
(16-18 March).
To schedule a meeting contact: info@preclinbiosystems.com

January 2009:
Preclin Biosystems AG was awarded financial support from the Volkswirtschaftsstiftung Read more...

October 2008: Preclin Biosystems AG wins 100,000 CHF in round 3 of Venture Kick. Read more...

August 2008: Dr. George Haas, previous worldwide Head of Research and Pre-Clinical Development of Ciba-Geigy Pharmaceuticals joins advisory board. Read more...

June 2008: Preclin Biosystems AG founded as an ETH spin off.. Read more...

May 2008: Preclin Biosystems announced as one of the winning teams of Venture 2008 out of over 100 participants. Read more...

March 2008: Dr. Ernst selected for Swiss Venture Leaders program. Read more...

February 2008: Preclin Biosystems announces Phase II funding support from Venture Kick. Read more...

January 2008: Novel method for the rapid modeling of chronic bronchitis and emphysema published in European Journal of Immunology. Read more...

November 2007: Preclin Biosystems announces Phase I funding support from Venture Kick. Read more...
HOME | ABOUT US | OUR MODELS | NEWS & LINKS | JOIN US | CONTACT | DISCLAIMER info@preclinbiosystems.com
© Preclin Biosystems AG, all rights reserved